Viewing Study NCT06435702


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-02-24 @ 8:48 AM
Study NCT ID: NCT06435702
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-30
First Post: 2024-05-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study
Sponsor: Peking University Third Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-06-01
Start Date Type: ESTIMATED
Primary Completion Date: 2026-07-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-26
First Submit QC Date: None
Study First Post Date: 2024-05-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-26
Last Update Post Date: 2024-05-30
Last Update Post Date Type: ACTUAL